|
|
Our Strategy
The MetaCyte team builds on relationships with researchers and scientists throughout the University of Louisville and beyond to identify potential health and life science start-ups. MetaCyte works in partnership with the inventor/potential co-founder to develop the idea and begin progression toward company development.
The initial evaluation process is rigorous, preparing viable companies for future investment.
When a concept is considered viable, MetaCyte co-founds a new company with the inventor, and begins to develop plans and identify needed resources to foster growth.
Steve Gailar, MetaCyte President and CEO , has said that there is no single formula for health science commercialization success - each inventor and idea has a distinctive starting point, target market and potential.
However, all MetaCyte companies have one trait in common - milestone-driven development pathways.
The MetaCyte team works to create a unique milestone-driven development pathway for each portfolio company; a clear set of development objectives designed to advance translational research rapidly from discovery to a proof-of-concept development stage that will support further financing.
In certain unique situations, MetaCyte will work with an early stage operating company, providing critical capabilities that facilitate the next stage of development or funding. In these cases, MetaCyte tailors a defined service agreement to insure needed support - general or operational management - as well as planning is delivered to achieve the anticipated milestone.
|
|
